Funding round
Azurity Pharmaceuticals Growth
Reported as "Growth Equity"
Azurity Pharmaceuticals, which works in specialty pharmaceutical development in Woburn, raised $1.10B in a Growth round announced on 18 Mar 2026, led by HarbourVest. 3 firms took part, 3 of them already investors.
$1.10B
Amount raised
Not disclosed
Post-money valuation
3
Investors
1 lead
Valuation
What this round says about the price
Azurity Pharmaceuticals did not disclose a valuation in this round. It is Azurity Pharmaceuticals' first venture round on record, 26 years after it was founded in 2000. No later venture round is on record for Azurity Pharmaceuticals.
Azurity Pharmaceuticals' funding rounds
This is the only venture round on record for Azurity Pharmaceuticals.
- Growth this round 18 Mar 2026, led by HarbourVest $1.10B
Investors
Who put money in
HarbourVest led the round with 2 other firms. HarbourVest, Pantheon and Audax Strategic Capital had backed Azurity Pharmaceuticals before.
Lead investor
- HarbourVest backs 37 venture-backed companies existing investor
Also in the round
- backs 8 venture-backed companies existing investor
- existing investor
Comparable rounds
How it compares
26 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $73M, and this round was 15 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 17 Mar 2026 | $30M | not disclosed | not named |
| Pharmaceutical Products | 2 Apr 2026 | $123M | not disclosed | Access Biotechnology and Alexandria Venture Investments |
| Pharmaceutical Products | 2 Apr 2026 | $85M | not disclosed | not named |
| Pharmaceutical Products | 29 Apr 2026 | $25M | not disclosed | Thairm Bio and Scottish National Investment Bank |
| Pharmaceutical Products | 7 May 2026 | $250M | not disclosed | Blackstone |
| Pharmaceutical Products | 14 Jan 2026 | undisclosed | not disclosed | 1315 Capital |
| Pharmaceutical Products | 24 Jun 2026 | $100M | not disclosed | Decheng Capital |
| Pharmaceutical Products | 4 Dec 2025 | $53M | not disclosed | LAV and ARCH Venture Partners |
Sources
Where this comes from
Reported by 2 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Azurity Pharmaceuticals raise in its Growth round?
Azurity Pharmaceuticals raised $1.10B in its Growth round, announced in Mar 2026.
Who led Azurity Pharmaceuticals' Growth round?
HarbourVest led it, with Pantheon and Audax Strategic Capital.
What was Azurity Pharmaceuticals' valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
26 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $73M, and this round was 15 times the median.